Clinical Trial Update: A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of subcutaneous Efgartigimod with PH20 technology in adults with systemic sclerosis, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Efgartigimod (efgartigimod)

Snippet

Sponsor: argenx | Conditions: Systemic Sclerosis (SSc) | Phase 2 | Status: RECRUITING